Life Science

A reversible and selective inhibitor of calpain I (&mu-calpain, Ki = 19 nM), with lower affinities for calpain II (m-calpain, Ki = 120 nM) and cathepsin B (Ki = 750 nM).

A reversible and selective inhibitor of calpain I (&mu-calpain, Ki = 19 nM), with lower affinities for calpain II (m-calpain, Ki = 120 nM) and cathepsin B (Ki = 750 nM).

A reversible and selective inhibitor of calpain I (&mu-calpain, Ki = 19 nM), with lower affinities for calpain II (m-calpain, Ki = 120 nM) and cathepsin B (Ki = 750 nM).

A cell-penetrating peptide inhibitor of calpain (IC₅₀ = 5 nM) which completely abolishes calpain activity in platelets also a potent inhibitor of cathepsin K (IC₅₀ = 0.11 nM).

A cell-penetrating peptide inhibitor of calpain (IC₅₀ = 5 nM) which completely abolishes calpain activity in platelets also a potent inhibitor of cathepsin K (IC₅₀ = 0.11 nM).

A cell-penetrating peptide inhibitor of calpain (IC₅₀ = 5 nM) which completely abolishes calpain activity in platelets also a potent inhibitor of cathepsin K (IC₅₀ = 0.11 nM).

A cell-penetrating peptide inhibitor of calpain (IC₅₀ = 5 nM) which completely abolishes calpain activity in platelets also a potent inhibitor of cathepsin K (IC₅₀ = 0.11 nM).

A specific PKC inhibitor (IC₅₀ = 50 nM versus an IC₅₀ &gt 50 &muM for PKA) whose activation depends on exposure to light also inhibits phospholipase D1 and D2 (IC₅₀s = 100 nM) demonstrates antitumor activity.

A specific PKC inhibitor (IC₅₀ = 50 nM versus an IC₅₀ &gt 50 &muM for PKA) whose activation depends on exposure to light also inhibits phospholipase D1 and D2 (IC₅₀s = 100 nM) demonstrates antitumor activity.

Camel IFN-I3(Interferon Gamma) ELISA Kit

Camel IL-10 ELISA Kit (CLFI0003)

A trypsin-like protease inhibitor known to inhibit trypsin and various inflammatory proteases including plasmin, kallikrein, and thrombin used in the treatment of chronic pancreatitis and various manifestations of fibrosis.